{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:19:12Z","timestamp":1785403152042,"version":"3.56.0"},"reference-count":57,"publisher":"American Association for Cancer Research (AACR)","issue":"6","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH- 20-1-0210"],"award-info":[{"award-number":["W81XWH- 20-1-0210"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA24920"],"award-info":[{"award-number":["R01CA24920"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA303124"],"award-info":[{"award-number":["R01CA303124"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015194","name":"Feist-Weiller Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lethal prostate cancer disproportionately affects African American (AA) men, who experience a higher incidence and earlier onset compared with European American (EA) men, reflecting a persistent biological and clinical disparity. Recent studies have implicated race-associated differences in lipid metabolic reprogramming as key contributors to this disparity. We recently identified carcinoma-associated fibroblasts (CAF) as a major stromal component that mediates racial disparities in tumor progression. Here, we demonstrate that lipid-laden CAFs from AA patients (AACAF) display enhanced protumorigenic properties compared with CAFs from EA patients (EACAF). Lipid droplet (LD) biogenesis and storage analysis revealed a robust diacylglycerol O-acyltransferase 1 (DGAT1) enzyme-dependent LD accumulation in AACAF. Ectopic DGAT1 expression in benign fibroblasts induced CAF markers\u2019 (FAP1 and \u03b1SMA) expression linked to fibroblast activation, altered the secretome, and significantly enhanced prostate cancer cells\u2019 growth in vivo. Integrative transcriptomic and secretome analyses identified novel DGAT1-regulated genes involved in CAF linked to metabolism, cell\u2013cell communication, motility, and angiogenesis, mediated mainly through ERK1\/2 signaling activation. Pharmacologic DGAT1 inhibition suppressed these pathways and elicited racially distinct regulation of tumor-promoting mediators, including BDNF, VEGF, and TSP1. Mechanistic experiments show that functionally, lipid-laden CAFs from AA patients exhibit increased fibroblast activation and a secretory phenotype with greater protumor activity compared with CAFs from EA patients. Collectively, these findings reveal that DGAT1 is a pivotal enzymatic regulator of fibroblast activation and lipid-driven remodeling in the prostate cancer tumor microenvironment of AA men. Targeting DGAT1 represents a promising strategy to disrupt metabolic\u2013stromal cross-talk and mitigate race-associated disparities in prostate cancer progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study highlights DGAT1-driven lipid accumulation in CAFs from AA patients with prostate cancer as a key driver of fibroblast activation and tumor-promoting roles contributing to racial disparities. Targeting DGAT1 disrupts lipid-mediated cancer\u2013stroma interactions, offering a new therapeutic strategy to reduce aggressive prostate cancer in AA men.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0701","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:52:57Z","timestamp":1778608377000},"page":"1305-1318","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DGAT1 Drives Racially Divergent Fibroblast Activation via ERK1\/2-Dependent Tumorigenic Signaling in Prostate Cancer"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-5485","authenticated-orcid":false,"given":"Sathyavathi","family":"ChallaSivaKanaka","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7206-9539","authenticated-orcid":false,"given":"Mamatha","family":"Kakarla","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-9221","authenticated-orcid":false,"given":"Renee E.","family":"Vickman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."},{"name":"2Pritzker School of Medicine, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4722-5622","authenticated-orcid":false,"given":"Yana","family":"Filipovich","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9745-9418","authenticated-orcid":false,"given":"Philip","family":"Fitchev","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-5580","authenticated-orcid":false,"given":"Md Maksudul","family":"Alam","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Biology, Louisiana State University Health Shreveport, Shreveport, Louisiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0688-7024","authenticated-orcid":false,"given":"Md Niaz","family":"Morshed","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Biology, Louisiana State University Health Shreveport, Shreveport, Louisiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2986-1778","authenticated-orcid":false,"given":"Pooja","family":"Talaty","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7707-3318","authenticated-orcid":false,"given":"Brian T.","family":"Helfand","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."},{"name":"2Pritzker School of Medicine, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1905-7467","authenticated-orcid":false,"given":"David","family":"Price","sequence":"additional","affiliation":[{"name":"4Feist-Weiller Cancer Center, Louisiana State University Health Shreveport, Shreveport, Louisiana."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6059-6550","authenticated-orcid":false,"given":"Simon W.","family":"Hayward","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."},{"name":"2Pritzker School of Medicine, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-5000","authenticated-orcid":false,"given":"Susan E.","family":"Crawford","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04tpp9d61","id-type":"ROR","asserted-by":"publisher"}],"name":"NorthShore University HealthSystem 1 Department of Surgery, , Evanston, Illinois."},{"name":"2Pritzker School of Medicine, University of Chicago, Chicago, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-9506","authenticated-orcid":false,"given":"Omar E.","family":"Franco","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Molecular Biology, Louisiana State University Health Shreveport, Shreveport, Louisiana."},{"name":"4Feist-Weiller Cancer Center, Louisiana State University Health Shreveport, Shreveport, Louisiana."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2026060402013709700_bib1","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1186\/s12889-025-25694-6","article-title":"Temporal trends and regional disparities in prostate cancer mortality in the United States, 1999\u20132023: an analysis of the CDC WONDER database","volume":"25","author":"Chai","year":"2025","journal-title":"BMC Public Health"},{"key":"2026060402013709700_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41585-024-00948-x","article-title":"Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards","volume":"22","author":"Dee","year":"2025","journal-title":"Nat Rev Urol"},{"key":"2026060402013709700_bib3","first-page":"485","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"2026060402013709700_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12916-025-04448-6","article-title":"Rising metastatic prostate cancer rates but narrowing racial gap","volume":"23","author":"Zurl","year":"2025","journal-title":"BMC Med"},{"key":"2026060402013709700_bib5","doi-asserted-by":"crossref","first-page":"e70979","DOI":"10.1002\/cam4.70979","article-title":"Understanding racial disparities in prostate cancer: a multifaceted approach","volume":"14","author":"Cobbs","year":"2025","journal-title":"Cancer Med"},{"key":"2026060402013709700_bib6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/1055-9965.EPI-21-1064","article-title":"Racial disparities in prostate cancer: evaluation of diet, lifestyle, family history, and screening patterns","volume":"31","author":"Hansen","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026060402013709700_bib7","first-page":"2235","article-title":"Racial disparities in the molecular landscape of cancer","volume":"38","author":"Heath","year":"2018","journal-title":"Anticancer Res"},{"key":"2026060402013709700_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2022.01.028","article-title":"Racial disparities in prostate cancer: a complex interplay between socioeconomic inequities and genomics","volume":"531","author":"Lowder","year":"2022","journal-title":"Cancer Lett"},{"key":"2026060402013709700_bib9","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1158\/0008-5472.CAN-17-3810","article-title":"Elevation of stromal-derived mediators of inflammation promote prostate cancer progression in African-American men","volume":"78","author":"Gillard","year":"2018","journal-title":"Cancer Res"},{"key":"2026060402013709700_bib10","doi-asserted-by":"crossref","first-page":"217865","DOI":"10.1016\/j.canlet.2025.217865","article-title":"The role of tumor microenvironment and immune cell crosstalk in triple-negative breast cancer (TNBC): emerging therapeutic opportunities","volume":"628","author":"Sabit","year":"2025","journal-title":"Cancer Lett"},{"key":"2026060402013709700_bib11","first-page":"214","article-title":"Racial differences in prostate tumor microenvironment: implications for disparate clinical outcomes and potential opportunities","volume":"6","author":"Goswami","year":"2022","journal-title":"Cancer Health Disparities"},{"key":"2026060402013709700_bib12","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.3390\/cancers13112656","article-title":"Race as a contributor to stromal modulation of tumor progression","volume":"13","author":"Kakarla","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026060402013709700_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/cancers18010151","article-title":"Targeting cancer-associated fibroblasts in prostate cancer: recent advances and therapeutic opportunities","volume":"18","author":"Chen","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026060402013709700_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2021.10.028","article-title":"Fibroblast heterogeneity in prostate carcinogenesis","volume":"525","author":"ChallaSivaKanaka","year":"2022","journal-title":"Cancer Lett"},{"key":"2026060402013709700_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1186\/s12967-025-06744-4","article-title":"Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"2026060402013709700_bib16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/QAI.0000000000002831","article-title":"Differential associations between BDNF and memory across older Black and White adults with HIV disease","volume":"89","author":"Fazeli","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026060402013709700_bib17","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s12640-021-00406-1","article-title":"Race-dependent association of single-nucleotide polymorphisms in Trkb receptor in people living with HIV and depression","volume":"39","author":"Avdoshina","year":"2021","journal-title":"Neurotox Res"},{"key":"2026060402013709700_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41556-024-01364-4","article-title":"Lipid droplets and cellular lipid flux","volume":"26","author":"Mathiowetz","year":"2024","journal-title":"Nat Cell Biol"},{"key":"2026060402013709700_bib19","doi-asserted-by":"crossref","first-page":"jcs213579","DOI":"10.1242\/jcs.213579","article-title":"PEDF regulates plasticity of a novel lipid-MTOC axis in prostate cancer-associated fibroblasts","volume":"131","author":"Nardi","year":"2018","journal-title":"J Cell Sci"},{"key":"2026060402013709700_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12944-019-1130-4","article-title":"Racial differences in distribution of fatty acids in prostate cancer and benign prostatic tissues","volume":"18","author":"Zhou","year":"2019","journal-title":"Lipids Health Dis"},{"key":"2026060402013709700_bib21","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-10-3142","article-title":"Altered TGF-beta signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis","volume":"71","author":"Franco","year":"2011","journal-title":"Cancer Res"},{"key":"2026060402013709700_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF02631333","article-title":"Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1","volume":"31","author":"Hayward","year":"1995","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2026060402013709700_bib23","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41374-021-00583-9","article-title":"Loss of ephrin B2 receptor (EPHB2) sets lipid rheostat by regulating proteins DGAT1 and ATGL inducing lipid droplet storage in prostate cancer cells","volume":"101","author":"Morales","year":"2021","journal-title":"Lab Invest"},{"key":"2026060402013709700_bib24","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1038\/s41598-019-39537-z","article-title":"DGAT1 inhibitor suppresses prostate tumor growth and migration by regulating intracellular lipids and non-centrosomal MTOC protein GM130","volume":"9","author":"Nardi","year":"2019","journal-title":"Sci Rep"},{"key":"2026060402013709700_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"2026060402013709700_bib26","doi-asserted-by":"crossref","first-page":"1442740","DOI":"10.3389\/fendo.2024.1442740","article-title":"Association between metabolic obesity phenotypes and the risk of developing prostate cancer: a propensity score matching study based on Xinjiang","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026060402013709700_bib27","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41374-019-0296-8","article-title":"Lipid droplet velocity is a microenvironmental sensor of aggressive tumors regulated by V-ATPase and PEDF","volume":"99","author":"Nardi","year":"2019","journal-title":"Lab Invest"},{"key":"2026060402013709700_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamaoncol.2015.0513","article-title":"Difference in association of obesity with prostate cancer risk between US African American and non-Hispanic white men in the Selenium and Vitamin E Cancer Prevention Trial (SELECT)","volume":"1","author":"Barrington","year":"2015","journal-title":"JAMA Oncol"},{"key":"2026060402013709700_bib29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41585-023-00764-9","article-title":"Obesity and prostate cancer - microenvironmental roles of adipose tissue","volume":"20","author":"Saha","year":"2023","journal-title":"Nat Rev Urol"},{"key":"2026060402013709700_bib30","doi-asserted-by":"crossref","first-page":"34485","DOI":"10.18632\/oncotarget.26128","article-title":"Abdominal obesity and prostate cancer risk: epidemiological evidence from the EPICAP study","volume":"9","author":"Lavalette","year":"2018","journal-title":"Oncotarget"},{"key":"2026060402013709700_bib31","first-page":"235","article-title":"General obesity and prostate cancer in relation to abdominal obesity and ethnic groups: a US population-based cross-sectional study","volume":"16","author":"Ahmed","year":"2024","journal-title":"Res Rep Urol"},{"key":"2026060402013709700_bib32","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/ijms17091430","article-title":"Lipid droplets: a key cellular organelle associated with cancer cell survival under normoxia and hypoxia","volume":"17","author":"Koizume","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026060402013709700_bib33","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/ijc.31775","article-title":"Adipose tissue-derived stromal cells are sources of cancer-associated fibroblasts and enhance tumor progression by dense collagen matrix","volume":"144","author":"Okumura","year":"2019","journal-title":"Int J Cancer"},{"key":"2026060402013709700_bib34","doi-asserted-by":"crossref","first-page":"9216502","DOI":"10.1155\/2017\/9216502","article-title":"Obesity enhances the conversion of adipose-derived stromal\/stem cells into carcinoma-associated fibroblast leading to cancer cell proliferation and progression to an invasive phenotype","volume":"2017","author":"Strong","year":"2017","journal-title":"Stem Cells Int"},{"key":"2026060402013709700_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41391-021-00451-z","article-title":"Racial disparities in prostate cancer among Black men: epidemiology and outcomes","volume":"25","author":"Chowdhury-Paulino","year":"2022","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026060402013709700_bib36","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"2026060402013709700_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12916-022-02336-x","article-title":"Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies","volume":"20","author":"Perez-Cornago","year":"2022","journal-title":"BMC Med"},{"key":"2026060402013709700_bib38","doi-asserted-by":"crossref","first-page":"645400","DOI":"10.3389\/fcell.2021.645400","article-title":"FGF10 and lipofibroblasts in lung homeostasis and disease: insights gained from the adipocytes","volume":"9","author":"Lv","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2026060402013709700_bib39","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1186\/s12967-025-07164-0","article-title":"Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells","volume":"23","author":"Zhang","year":"2025","journal-title":"J Transl Med"},{"key":"2026060402013709700_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1164\/rccm.202101-0043LE","article-title":"Lipofibroblasts in structurally normal, fibrotic, and emphysematous human lungs","volume":"204","author":"Schipke","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060402013709700_bib41","doi-asserted-by":"crossref","first-page":"33472","DOI":"10.18632\/oncotarget.8098","article-title":"The application of the fibroblast activation protein alpha-targeted immunotherapy strategy","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"2026060402013709700_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/j.semnuclmed.2025.11.022","article-title":"Current status of FAP therapy in solid tumors","volume":"56","author":"Siegmund","year":"2026","journal-title":"Semin Nucl Med"},{"key":"2026060402013709700_bib43","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1158\/0008-5472.CAN-23-3252","article-title":"Dissecting FAP+ cell diversity in pancreatic cancer uncovers an interferon-response subtype of cancer-associated fibroblasts with tumor-restraining properties","volume":"85","author":"Cumming","year":"2025","journal-title":"Cancer Res"},{"key":"2026060402013709700_bib44","first-page":"32","article-title":"Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer","volume":"7","author":"Tokhanbigli","year":"2024","journal-title":"Cancer Drug Resist"},{"key":"2026060402013709700_bib45","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.3390\/cancers14163906","article-title":"Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2026060402013709700_bib46","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2017.03.021","article-title":"Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer","volume":"486","author":"Ni","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2026060402013709700_bib47","doi-asserted-by":"crossref","first-page":"1554312","DOI":"10.3389\/fcell.2025.1554312","article-title":"The role of tenascin-C in tumor microenvironments and its potential as a therapeutic target","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"2026060402013709700_bib48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2019-319200","article-title":"STAT3 activation through IL-6\/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis","volume":"69","author":"Heichler","year":"2020","journal-title":"Gut"},{"key":"2026060402013709700_bib49","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41698-025-01046-w","article-title":"Targeting cancer-associated fibroblast-driven LIF\/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer","volume":"9","author":"Bhatia","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"2026060402013709700_bib50","doi-asserted-by":"crossref","first-page":"1691661","DOI":"10.3389\/fimmu.2025.1691661","article-title":"Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"2026060402013709700_bib51","doi-asserted-by":"crossref","first-page":"1601756","DOI":"10.3389\/fimmu.2025.1601756","article-title":"Chemokines: humble yet mighty players in the tumour microenvironment","volume":"16","author":"Xavier","year":"2025","journal-title":"Front Immunol"},{"key":"2026060402013709700_bib52","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm870","article-title":"Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas","volume":"9","author":"Doll","year":"2003","journal-title":"Nat Med"},{"key":"2026060402013709700_bib53","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/cancers16030510","article-title":"The various roles of PEDF in cancer","volume":"16","author":"Elmi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026060402013709700_bib54","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3389\/fncel.2018.00522","article-title":"The role of BDNF in peripheral nerve regeneration: activity-dependent treatments and Val66Met","volume":"12","author":"McGregor","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"2026060402013709700_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"2026060402013709700_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1172\/JCI200522655","article-title":"Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors","volume":"115","author":"Kermani","year":"2005","journal-title":"J Clin Invest"},{"key":"2026060402013709700_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s40478-025-02181-y","article-title":"Brain-derived neurotrophic factor supports pericyte and vascular homeostasis in the aging brain","volume":"13","author":"Luo","year":"2025","journal-title":"Acta Neuropathol Commun"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0701\/3793733\/crc-25-0701.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1305\/3799888\/crc-25-0701.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/6\/1305\/3799888\/crc-25-0701.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:01:54Z","timestamp":1780552914000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/6\/1305\/785606\/DGAT1-Drives-Racially-Divergent-Fibroblast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0701","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.32576192","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576207","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576198","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576195","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576213","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576201","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576210","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576189","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576216","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.32576204","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8517017","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}